Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders

Latha Soorya, Jessica Kiarashi, Eric Hollander

Research output: Contribution to journalReview articlepeer-review

56 Scopus citations


This article provides an overview of psychopharmacological treatments for repetitive behaviors in autism spectrum disorders (ASDs) in the context of current conceptualizations of this understudied core symptom domain. The available literature on the widely used selective serotonin reuptake inhibitors (SSRIs), including fluvoxamine, fluoxetine, citalopram, escitalopram, and sertraline, are reviewed. In addition to SSRIs, research on effects of other pharmacologic interventions such as divalproex sodium, risperidone, and the neuropeptide oxytocin are presented. To date, data are mixed for interventions commonly prescribed in clinical practice and suggest several areas of investigation in advancing research on the medication management of repetitive behaviors.

Original languageEnglish (US)
Pages (from-to)753-771
Number of pages19
JournalChild and Adolescent Psychiatric Clinics of North America
Issue number4
StatePublished - Oct 2008
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health


Dive into the research topics of 'Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders'. Together they form a unique fingerprint.

Cite this